Modelling the long QT syndrome with induced pluripotent stem cells
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The ability to generate patient-specific human induced pluripotent stem cells (iPSCs) offers a new paradigm for modelling human disease and for individualizing drug testing. Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death. Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I(Kr). Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K(ATP)-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
In the citing paper
“Type-2 LQTS patients’ iPSC-derived cardiomyocytes showed that a mutation in KCNH2 causes action-potential-duration prolongation by reducing the cardiac potassium current IKr and dysfunction of the sodium ion channel [7,8,9].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112131 · Cited by 1,536
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Cited by
Items 501–600 of 1,000
Bekhite, M. M., & Schulze, P. C. (2021) · Cells · doi:10.3390/cells10123483 · Cited by 25
Basic Research Approaches to Evaluate Cardiac Arrhythmia in Heart Failure and Beyond
Cumberland, M. J., Riebel, L. L., Roy, A., O’Shea, C., Holmes, A. P., Denning, C. N., Kirchhof, P. F., Rodríguez, B., & Gehmlich, K. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.806366 · Cited by 23
Kamdar, F. D., Kamdar, A. K., Koyano‐Nakagawa, N., Garry, M. G., & Garry, D. J. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.04.010 · Cited by 22
Huang, H., Chuang, C.-Y., & Kuo, H. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt125 · Cited by 23
Jiang, B., Jen, M. C., Perrin, L., Wertheim, J. A., & Ameer, G. A. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0191 · Cited by 23
Young, W. (2012) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.s10-010 · Cited by 24
Disease-Inspired Tissue Engineering: Investigation of Cardiovascular Pathologies
Simon, L. R., & Masters, K. S. B. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01067 · Cited by 22
Schwan, J., & Campbell, S. G. (2015) · Biomarker Insights · doi:10.4137/bmi.s23912 · Cited by 23
Direct Reprogramming into Desired Cell Types by Defined Factors
Ieda, M. (2013) · The Keio Journal of Medicine · doi:10.2302/kjm.2012-0017-re · Cited by 24
White, M. C., Pang, L., & Yang, X. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.05.025 · Cited by 21
Winbo, A., Ramanan, S., Eugster, E., Rydberg, A., Jovinge, S. V., Skinner, J. R., & Montgomery, J. M. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01002.2020 · Cited by 21
Gruber, A., Edri, O., Huber, I., Arbel, G., Gepstein, A., Shiti, A., Shaheen, N., Chorna, S. V., Landesberg, M., & Gepstein, L. (2021) · JCI Insight · doi:10.1172/jci.insight.147470 · Cited by 20
Self-citationPang, J. K. S., Ho, B. X., Chan, W., & Soh, B.-S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.788955 · Cited by 25
Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic Diseases
Antonucci, I., Provenzano, M., Rodrigues, M., Pantalone, A., Salini, V., Ballerini, P., Borlongan, C. V., & Stuppia, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040607 · Cited by 20
Gene delivery methods and genome editing of human pluripotent stem cells
Czerwińska, P., Mazurek, S., Kołodziejczak, I., & Wiznerowicz, M. (2019) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2019.01.007 · Cited by 21
Jonsson, M. K. B., van der Heyden, M. A. G., & van Veen, T. A. B. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.06.011 · Cited by 20
Li, J., Minami, I., Yu, L., Tsuji, K., Nakajima, M., Qiao, J., Suzuki, M., Shimono, K., Nakatsuji, N., Kotera, H., et al. (2016) · Stem Cells International · doi:10.1155/2016/2634013 · Cited by 22
Innovation in safety pharmacology testing
Pugsley, M. K., Towart, R., Authier, S., Gallacher, D. J., & Curtis, M. J. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2011.05.005 · Cited by 20
Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling
Gharanei, M., Shafaattalab, S., Sangha, S. S., Gunawan, M. G., Laksman, Z., Hove‐Madsen, L., & Tibbits, G. F. (2021) · Methods · doi:10.1016/j.ymeth.2021.06.009 · Cited by 21
Simons, E., Loeys, B., & Alaerts, M. (2023) · Biomedicines · doi:10.3390/biomedicines11020334 · Cited by 24
Giannetti, F., Barbieri, M., Shiti, A., Casini, S., Sager, P. T., Das, S., Pradhananga, S., Srinivasan, D. K., Nimani, S., Alerni, N., et al. (2023) · EP Europace · doi:10.1093/europace/euad094 · Cited by 20
Self-citationModeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues
Maurissen, T. L., Kawatou, M., López-Dávila, V., Minatoya, K., Yamashita, J. K., & Woltjen, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-52871-1 · Cited by 19
Hodge, A. J., Zhong, J., & Lipke, E. A. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25849 · Cited by 19
A review of Rett syndrome (RTT) with induced pluripotent stem cells
Vellingiri, B., Dhivya, V., Mohan, G., Mohanadevi, S., Venkatesh, B., & Geetha, B. (2016) · Stem Cell Investigation · doi:10.21037/sci.2016.09.05 · Cited by 20
Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis
Parveen, S., Singh, S. P., Panicker, M. M., & Gupta, P. K. (2019) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-019-00321-y · Cited by 21
Li, W., Luo, X., Ulbricht, Y., & Guan, K. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102565 · Cited by 19
Preclinical short QT syndrome models: studying the phenotype and drug-screening
Fan, X., Yang, G., Kowitz, J., Duru, F., Saguner, A. M., Akın, İ., Zhou, X., & El‐Battrawy, I. (2021) · EP Europace · doi:10.1093/europace/euab214 · Cited by 21
Advances and applications of induced pluripotent stem cells
Pietronave, S., & Prat, M. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y11-125 · Cited by 19
High frequency resonant waveguide grating imager for assessing drug-induced cardiotoxicity
Ferrie, A. M., Wu, Q., Deichmann, O. D., & Ye, F. (2014) · Applied Physics Letters · doi:10.1063/1.4876095 · Cited by 19
Chakraborty, S., Christoforou, N., Fattahi, A., Herzog, R. W., & Leong, K. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064342 · Cited by 22
Optogenetic stimulation of multiwell MEA plates for neural and cardiac applications
Clements, I. P., Millard, D. C., Nicolini, A. M., Preyer, A. J., Grier, R., Heckerling, A., Blum, R. A., Tyler, P., McSweeney, K. M., Lu, Y., et al. (2016) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2213708 · Cited by 19
Bayzigitov, D. R., Medvedev, S. P., Dementyeva, E. V., Афгановна, Б. С., Pokushalov, E. A., Karaskov, A. M., & Zakian, S. M. (2016) · Cardiology Research and Practice · doi:10.1155/2016/3582380 · Cited by 21
Kalra, R. S., Dhanjal, J. K., Das, M., Singh, B., & Naithani, R. (2021) · Cells · doi:10.3390/cells10102558 · Cited by 21
Song, Y., Zheng, Z., & Lian, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.889519 · Cited by 18
iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity
Lee, T. Y. T., Coles, J. G., & Maynes, J. T. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1308217 · Cited by 21
The Promise of Human Induced Pluripotent Stem Cells in Dental Research
Srijaya, T. C., Pradeep, P. J., Zain, R. B., Musa, S., Kasim, N. H. A., & Govindasamy, V. (2012) · Stem Cells International · doi:10.1155/2012/423868 · Cited by 20
Transcription factor‐mediated reprogramming: epigenetics and therapeutic potential
Firas, J., Liu, X., Lim, S. M., & Polo, J. M. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.5 · Cited by 19
Wei, H., Zhang, G., Qiu, S., Lü, J., Sheng, J., Manasi, Tan, G., Wong, P., Gan, S. U., & SHIM, W. S. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050641 · Cited by 18
Rajasingh, S., Isai, D. G., Samanta, S., Zhou, Z., Dawn, B., Kinsey, W. H., Czirók, A., & Rajasingh, J. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.183 · Cited by 18
hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation
Chang, Y., Li, Y., Bai, R., Wu, F., Ma, S., Saleem, A., Zhang, S., Jiang, Y., Dong, T., Guo, T., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02346-1 · Cited by 18
Clemens, D. J., Ye, D., Zhou, W., Kim, C. S. J., Pease, D. R., Navaratnarajah, C. K., Barkhymer, A. J., Tester, D. J., Nelson, T. J., Cattaneo, R., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282151 · Cited by 20
Friedrichs, S., Malan, D., & Sasse, P. (2012) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.09.006 · Cited by 19
Dolatshad, N. F., Hellen, N., Jabbour, R. J., Harding, S. E., & Földes, G. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00076 · Cited by 20
Genome Engineering in Human Cells
Song, M., Kim, Y., Kim, J., & Kim, S. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801185-0.00005-2 · Cited by 18
Linthout, S. V., Tschöpe, C., & Schultheiß, H. (2014) · Circulation Research · doi:10.1161/circresaha.114.304951 · Cited by 19
Modelling Long QT Syndrome With iPS Cells: Be Still, My Beating Heart …
Tiscórnia, G., Monserrat, N., & Belmonte, J. C. I. (2011) · Circulation Research · doi:10.1161/res.0b013e318216f0db · Cited by 19
Fan, X., Yang, G., Duru, F., Grilli, M., Akın, İ., Zhou, X., Saguner, A. M., & El‐Battrawy, I. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10615-0 · Cited by 17
Clark, A. P., Wei, S., Fullerton, K. E., Krogh‐Madsen, T., & Christini, D. J. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00063.2024 · Cited by 13
Soft 3D Bioelectrodes for Intraorganoid Signal Monitoring in Cardiac Models
Park, Y., Kim, S., Min, S., Kim, E., Kim, D., Cho, Y. H., Kim, S., Joo, H., Jeong, I., Lim, J. A., et al. (2025) · Nano Letters · doi:10.1021/acs.nanolett.5c00069 · Cited by 18
Marcu, I. C., Illaste, A., Heuking, P., Jaconi, M. E., & Ullrich, N. D. (2015) · Stem Cells · doi:10.1002/stem.2009 · Cited by 18
An Electrifying iPSC Disease Model: Long QT Syndrome Type 2 and Heart Cells in a Dish
Kamp, T. J. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.01.010 · Cited by 17
Generation of Cardiomyocytes from Pluripotent Stem Cells
Nakahama, H., & Pasquale, E. D. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_173 · Cited by 18
Kuusela, J., Larsson, K., Shah, D. A., Prajapati, C., & Aalto‐Setälä, K. (2017) · Biology Open · doi:10.1242/bio.024216 · Cited by 19
Zhong, R., Schimanski, T., Zhang, F., Lan, H., Hohn, A., Xu, Q., Huang, M., Liao, Z., Lin, Q., Yang, Z., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158313 · Cited by 17
Lombardi, R. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32835fb7f3 · Cited by 19
Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy
Saha, M., Rizzo, S. A., Ramanathan, M., Hightower, R. M., Santostefano, K. E., Terada, N., Finkel, R. S., Berg, J. S., Chahin, N., Pacak, C. A., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz064 · Cited by 17
Assessment of Cardiotoxicity With Stem Cell-based Strategies
Stoter, A. M. S., Hirt, M. N., Stenzig, J., & Weinberger, F. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.08.012 · Cited by 18
Priori, S. G. (2011) · Circulation Research · doi:10.1161/circresaha.111.253724 · Cited by 17
Advances in Manufacturing Cardiomyocytes from Human Pluripotent Stem Cells
Floy, M. E., Shabnam, F., Simmons, A. D., Bhute, V. J., Jin, G., Friedrich, W. A., Steinberg, A. B., & Palecek, S. P. (2022) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-092120-033922 · Cited by 18
Seefeldt, J. M., Libai, Y., Berg, K., Jespersen, N. R., Lassen, T. R., Dalsgaard, F. F., Ryhammer, P. K., Pedersen, M., Ilkjær, L. B., Hu, M. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-51387-y · Cited by 18
Self-citationModelling Human Channelopathies Using Induced Pluripotent Stem Cells: A Comprehensive Review
Müller, M., Seufferlein, T. T. W., Illing, A., & Homann, J. M. (2013) · Stem Cells International · doi:10.1155/2013/496501 · Cited by 18
Evolution of iPSC disease models
Zhang, W., Ding, Z., & Liu, G. (2012) · Protein & Cell · doi:10.1007/s13238-012-2005-x · Cited by 16
Pilarczyk, G., Raulf, A., Gunkel, M., Fleischmann, B. K., Lemor, R. M., & Hausmann, M. (2016) · Journal of Functional Biomaterials · doi:10.3390/jfb7010001 · Cited by 16
Schork, N. J., & Nazor, K. L. (2017) · Advances in genetics · doi:10.1016/bs.adgen.2017.06.001 · Cited by 21
Molecular and Cellular Mechanisms in Heart Failure
Puggia, I., Rowland, T. J., Miyamoto, S. D., Sinagra, G., & Mestroni, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802393-8.00001-6 · Cited by 21
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Zhou, R., Xu, A., Tu, J., Liu, M., Gingold, J. A., Zhao, R., & Lee, D. (2018) · Journal of Visualized Experiments · doi:10.3791/57664 · Cited by 18
Lin, Y., Ni, X., Zhang, J., Ou, C., He, X., Dai, W., Chen, X., & Chen, M. (2020) · Bioscience Reports · doi:10.1042/bsr20193369 · Cited by 16
Ostrominski, J. W., Yada, R. C., Sato, N., Klein, M. G., Blinova, K., Patel, D., Valadez, R., Palisoc, M., Pittaluga, S., Peng, K.-W., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0019 · Cited by 16
Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome
Song, L., Bekdash, R., Morikawa, K., Quejada, J. R., Klein, A. D., Aina-Badejo, D., Yoshida, K., Yamamoto, H. E., Chalan, A., Yang, R., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-021-00016-2 · Cited by 16
Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome
Shiti, A., Arbil, G., Shaheen, N., Huber, I., Setter, N., & Gepstein, L. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.08.003 · Cited by 16
Self-citationThe genomic stability of induced pluripotent stem cells
Chen, Z., Zhao, T., & Xu, Y. (2012) · Protein & Cell · doi:10.1007/s13238-012-2922-8 · Cited by 18
Grunert, M., Appelt, S., Schoenhals, S., Mika, K., Cui, H., Cooper, A., Cyganek, L., Guan, K., & Sperling, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-67872-z · Cited by 17
Genotype-phenotype correlation in long QT syndrome
Baskar, S., & Aziz, P. F. (2015) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2015.26 · Cited by 20
Sogo, T., Morikawa, K., Kurata, Y., Li, P., Ichinose, T., Yuasa, S., Nozaki, D., Miake, J., Ninomiya, H., Shimizu, W., et al. (2016) · Regenerative Therapy · doi:10.1016/j.reth.2015.12.001 · Cited by 17
Developing insights into cardiac regeneration
Christoffels, V. M., & Pu, W. T. (2013) · Development · doi:10.1242/dev.096867 · Cited by 16
Functional evaluation of genetic variation in complex human traits
Peters, D. T., & Musunuru, K. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds363 · Cited by 15
Nakao, S., Ihara, D., Hasegawa, K., & Kawamura, T. (2020) · European Cardiology Review · doi:10.15420/ecr.2019.03 · Cited by 17
Human induced pluripotent stem cells for studying mitochondrial diseases in the heart
Caudal, A., Ren, L., Tu, C., & Wu, J. C. (2022) · FEBS Letters · doi:10.1002/1873-3468.14444 · Cited by 19
Ismaili, D., Schulz, C., Horváth, A., Koivumäki, J. T., Mika, D., Hansen, A., Eschenhagen, T., & Christ, T. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1132165 · Cited by 16
Jehle, J., Ficker, E. K., Wan, X., Deschênes, I., Kisselbach, J., Wiedmann, F., Staudacher, I., Schmidt, C., Schweizer, P. A., Becker, R., et al. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12002 · Cited by 15
Targeting cardiac potassium channels for state-of-the-art drug discovery
Walsh, K. B. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.983471 · Cited by 16
Friedrichs, S., Malan, D., Voß, Y., & Sasse, P. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4010102 · Cited by 16
Proteomics in the World of Induced Pluripotent Stem Cells
Lindoso, R. S., Kasai-Brunswick, T. H., Monnerat, G., Collino, F., Carvalho, A. B., de Carvalho, A. C. C., & Vieyra, A. R. (2019) · Cells · doi:10.3390/cells8070703 · Cited by 17
Targeting cell plasticity for regeneration: From in vitro to in vivo reprogramming
Romanazzo, S., Lin, K., Srivastava, P., & Kilian, K. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.08.007 · Cited by 17
Micheu, M. M., & Rosca, A. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i4.281 · Cited by 17
Cohesin-protein Shugoshin-1 controls cardiac automaticity via HCN4 pacemaker channel
Liu, D., Song, A. T., Qi, X., Vliet, P. P. V., Xiao, J., Xiong, F., Andelfinger, G., & Nattel, S. (2021) · Nature Communications · doi:10.1038/s41467-021-22737-5 · Cited by 16
Horváth, A., Christ, T., Koivumäki, J. T., Prondzynski, M., Zech, A. T. L., Spohn, M., Saleem, U., Mannhardt, I., Ulmer, B. M., Girdauskas, E., et al. (2020) · Cells · doi:10.3390/cells9010253 · Cited by 15
Haim, I. R., Gruber, A., Kazma, N., Bashai, C., Kinsbruner, H. L., & Caspi, O. (2025) · Circulation Heart Failure · doi:10.1161/circheartfailure.124.011690 · Cited by 17
Self-citationNovak, A., Lorber, A., Itskovitz‐Eldor, J., & Binah, O. (2012) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10086 · Cited by 17
ProspectiveIn VitroModels of Channelopathies and Cardiomyopathies
Kawaguchi, N., Hayama, E., Furutani, Y., & Nakanishi, T. (2012) · Stem Cells International · doi:10.1155/2012/439219 · Cited by 14
Sequiera, G. L., Mehta, A. K., Ooi, T. H., & SHIM, W. S. N. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.10.020 · Cited by 14
Investigative safety strategies to improve success in drug development
Atienzar, F., Delaunois, A. G., Brouta, F., Cornet, M., Fleurance, R., Gerets, H. H. J., Glineur, S., Hasselgren, C., Kießling, A., da Costa, A. N., et al. (2016) · JOURNAL OF MEDICINES DEVELOPMENT SCIENCES · doi:10.18063/jmds.v2i1.139 · Cited by 14
Induced Pluripotent Stem Cell for the Study and Treatment of Sickle Cell Anemia
Reis, L. C. J., Picanço‐Castro, V., Paes, B. C. M. F., Pereira, O. A., Gyuricza, I. G., de Araújo, F. T., Morato-Marques, M., Moreira, L. F., Costa, E. D. B. O., dos Santos, T. P. M., et al. (2017) · Stem Cells International · doi:10.1155/2017/7492914 · Cited by 14
Wang, Z., Wang, L., Liu, W., Hu, D., Gao, Y., Ge, Q., Liu, X., Li, L., Wang, Y., Wang, S., et al. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101483 · Cited by 14
Loya, K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386882-4.00011-6 · Cited by 16
Enhancing iPSC‐CM Maturation Using a Matrigel‐Coated Micropatterned PDMS Substrate
Jiménez‐Vázquez, E. N., Jain, A., & Jones, D. K. (2022) · Current Protocols · doi:10.1002/cpz1.601 · Cited by 16
Ahmad, F. S., Jin, Y., Grassam-Rowe, A., Zhou, Y., Yuan, M., Fan, X., Zhou, R., Mu-u-min, R., O’Shea, C., Ibrahim, A. M., et al. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0312 · Cited by 16
Maizels, L., Heller, E., Landesberg, M., Glatstein, S., Huber, I., Arbel, G., Gepstein, A., Aronson, D., Sharabi, S., Beinart, R., et al. (2024) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.123.012278 · Cited by 14
Self-citationInduced Pluripotent Stem Cells: How They Will Change the Practice of Cardiovascular Medicine
Wong, W. T., Sayed, N., & Cooke, J. P. (2013) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-9-4-206 · Cited by 16
Navigating the labyrinth of cardiac regeneration
Lambers, E., & Kume, T. (2016) · Developmental Dynamics · doi:10.1002/dvdy.24397 · Cited by 14
Metadata
- Authors
- Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., Boulos, M., & Gepstein, L.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Gepstein, Lior
- Venue
- Nature
- Published
- 2011-01-16
- Volume
- 471
- Issue
- 7337
- Pages
- 225-229
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2115644752
- Cited by
- 1,049
- References
- 28
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 46 · 2023: 27 · 2022: 53 · 2021: 68 · 2020: 47 · 2019: 55 · 2018: 60 · 2017: 71 · 2016: 87 · 2015: 97 · 2014: 84 · 2013: 111 · 2012: 123
- FWCI
- 86.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Israel Science Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- long QT syndrome type 2, KCNH2 mutation, induced pluripotent stem cells, iPSC-derived cardiomyocytes, action potential duration prolongation, drug screening, drug-induced arrhythmia, sudden cardiac death, calcium channel blockers, KATP channel openers, potassium channel blockers, arrhythmogenicity
- MeSH terms
- ERG1 Potassium Channel, Adult, Cells, Cultured, Drug Evaluation, Preclinical, Female, Fibroblasts, Humans, Long QT Syndrome, Models, Biological, Phenotype, Patch-Clamp Techniques, Mutation, Missense, Myocytes, Cardiac, Ether-A-Go-Go Potassium Channels, Embryonic Stem Cells, Cell Transdifferentiation, Induced Pluripotent Stem Cells, Precision Medicine, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.